Enumera Molecular
PrivateLast Round
Seed Round
Jul 16, 2026
Est. Valuation
$24M
Total Funding Raised
$24.83M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Enumera Molecular is a life science tools company that develops a scalable biomolecule assessment platform designed to simplify complex, high-analyte molecular testing for clinical liquid biopsy applications.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Precision Medicine
Business Model
B2B
Customer Profile
Usage-Based SaaS, Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Enumera Molecular Comparables
Compare Enumera Molecular with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| InvenireX | 84% | |
| Signatur Biosciences | 84% | |
| Proteins.1 | 83% |
Enumera Molecular Funding Rounds
Historical fundraising activity
Key People
Founding team and executive leadership
Enumera Molecular Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Arboretum Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 16, 2026
$12.3M raised in Seed Round funding.
- May 5, 2022
$13M round led by Arboretum Ventures.
Enumera Molecular Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Enumera Molecular's valuation, stock price, and market status.
Is Enumera Molecular a public or private company?
Enumera Molecular is a private company.
What is the current stock price of Enumera Molecular?
Enumera Molecular is a private company, so its shares have no public market price. Caplight tracks Enumera Molecular's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Enumera Molecular worth (valuation)?
Enumera Molecular's valuation is estimated at $24.0M based on funding round data.
Can I buy Enumera Molecular stock?
Enumera Molecular shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Enumera Molecular's last funding round?
Enumera Molecular's most recent funding round was Seed Round on July 16, 2026.
Who are the main investors in Enumera Molecular?
Key investors in Enumera Molecular include Arboretum Ventures.
Will Enumera Molecular IPO soon?
No public IPO plans have been announced for Enumera Molecular.
How can I track Enumera Molecular secondary market activity?
Caplight tracks bids, offers, and trades in Enumera Molecular's shares on secondary markets.